Hepatocyte growth factor in invasive growth of carcinomas

Cellular and Molecular Life Sciences

Volumn 64, Issue 11, 2007, Pages 1341-1354

  Desiderio, M A ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Carcinoma invasiveness; Chemokine receptor; E cadherins catenin; Hepatocyte growth factors; HIF 1 ; Met receptor; Transcription factors; Tumor microenvironment

Indexed keywords

BETA CATENIN; CHEMOKINE RECEPTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; TRANSCRIPTION FACTOR; UVOMORULIN;

APOPTOSIS; CANCER CELL; CANCER INVASION; CELL PROLIFERATION; CELL SURVIVAL; GENE TARGETING; HUMAN; HYPOXIA; NONHUMAN; PROTEIN ANALYSIS; PROTEIN FUNCTION; REVIEW; STROMA; TUMOR VASCULARIZATION;

ANIMALS; ANOXIA; APOPTOSIS; CADHERINS; CARCINOMA; CELL ADHESION; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HEPATOCYTE GROWTH FACTOR; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; MATRIX METALLOPROTEINASES; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; PHENOTYPE; PLASMINOGEN; PROTO-ONCOGENE PROTEINS C-MET; RECEPTORS, CHEMOKINE; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 34250016782     PISSN: 1420682X     EISSN: 15691632     Source Type: Journal    
DOI: 10.1007/s00018-007-7050-x     Document Type: Review

References (142)

1. Lu, H., Ouyang, W. and Huang, C. (2006) Inflammation, a key event in cancer development. Mol. Cancer Res. 4, 221-233.
2. Ducasse, M. and Brown, M. A. (2006) Epigenetic aberrations and cancer. Mol. Cancer 5, 60-70.
3. Lotem, J. and Sachs, L. (2006) Epigenetics and plasticity of differentiation in normal and cancer stem cells. Oncogene 25, 7663-7672.
4. Coussens, L. M. and Werb, Z. (2002) Inflammation and cancer. Nature 420, 860-867.
5. Melillo, G. and Semenza, G. L. (2006) Meeting report: exploiting the tumor microenvironment for therapeutics. Cancer Res. 66, 4558-4560.
6. Joyce, J. A. (2005) Therapeutic targeting of the tumor microenvironment. Cancer Cell 7, 513-520.
7. Farquhar, M. G. and Palade, G. E. (1963) Junctional complexex in various epithelia. J. Cell Biol. 17, 375-412.
8. Christiansen, J. J. and Rajasekaran, A. K. (2006) Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis. Cancer Res. 66, 8319-8326.
9. Thiery, J. P. and Sleeman, J. P. (2006) Complex networks orchestrate epithelial-mesenchymal transition. Nat. Rev. Mol. Cell. Biol. 7, 131-142.
10. Huber, M. A., Kraut, N. and Beug, H. (2005) Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr. Opin. Cell. Biol. 17, 548-558.
11. Thiery, J. P. (2003). Epithelial-mesenchymal transition in development and pathologies. Curr. Opin. Cell Biol. 15, 740-746.
12. Mazzone, M. and Comoglio, P. M. (2006) The Met pathway: master switch and drug target in cancer progression. FASEB J. 20, 1611-1621.
13. Birchmeier, C., Birchmeier, W., Gherardi, E. and Vande Woude, G. F. (2003) Met, metastasis, motility and more. Nat. Rev. 4, 915-925.
14. Matsumoto, K. and Nakamura, T. (1997) Hepatocyte growth factor (HGF) as a tissue organizer for organogenesis and regeneration. Biochem. Biophys. Res. Commun. 239, 639-644.
15. Trusolino, L., Cavassa, S., Angelini, P., Andò, M., Bertotti, A., Comoglio, P. M. and Boccaccio, C. (2000) HGF/scatter factor selectively promotes cell invasion by increasing integrin avidity. FASEB J. 14, 1629-1640.
16. Jiang, W. G., Martin, T. A. Parr, C., Davies, G., Matsumoto, K. and Nakamura, T. (2005) Hepatocyte growth factor, its receptor, and their potential value in cancer therapies. Crit. Rev. Oncol. Hematol. 53, 35-69.
17. Matsumoto, K. and Nakamura, T. (2006) Hepatocyte growth factor and the Met system as a mediator of tumor-stromal interactions. Int. J. Cancer 119, 477-483.
18. Comoglio, P. M. and Trusolino, L. (2002) Invasive growth: from development to metastasis. J. Clin. Invest. 109, 857-862.
19. Folgueras, A. R., Pendas, A. M., Sanchez, L. M. and Lopez-Otin, C. (2004) Matrix metalloproteinases in cancer: from new function to improved inhibition strategies. Int. J. Dev. Biol. 48, 411-424.
20. Overall, C. M. and Kleifeld, O. (2006) Tumor microenvironment-opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy. Nat. Rev. Cancer 6, 227-239.
21. Steeg, P. S. (2006) Tumor metastasis: mechanistic insights and clinical challenges. Nat. Med. 12, 895-904.
22. Gao, C.-F, Xie, Q., Su, Y.-L., Koeman, J., Khoo, S. K., Gustafson, M., Knudsen, B. S., Hay, R., Shinomiya, N. and Vande Woude, G. F. (2005) Proliferation and invasion: plasticity in tumor cells. Proc. Natl. Acad. Sci. USA 102, 10528-10533.
23. Bertotti, A. and Comoglio, P. M. (2003) Tyrosine kinase signaling specificity: lessons from the HGF receptor. Trends Biochem. Sci. 28, 527-533.
24. Boccaccio, C. and Comoglio, P. M. (2006) Invasive growth: a Met-driven genetic programme for cancer and stem cells. Nat. Rev. 6, 637-645.
25. Nakamura, T., Nishizawa, T., Hagiya, M., Seki, T., Shimonishi, M., Sugimura, A., Tashiro, K. and Shimizu, S. (1989) Molecular cloning and expression of human hepatocyte growth factor. Nature 342, 440-443.
26. Miyazawa, K., Tsubouchi, H., Naka, D., Takahashi, K., Okigaki, M., Arakaki, N., Nakayama, H., Hirono, S., Sakiyama, O., Takahashi, K., Gohda, E., Daikuhara, Y. and Kitamura, N. (1989) Molecular cloning and sequence analysis of cDNA for human hepatocyte growth factor. Biochem. Biophys. Res. Commun. 163, 967-973.
27. Miyazawa, K., Shimomura, T., Kitamura, A., Kondo, J., Morimoto, Y. and Kitamura, N. (1993). Molecular cloning and sequence analysis for a human serine protease responsible for activation of hepatocyte growth factor: structural similarity of the protease precursor to blood coagulation factor XII. J. Biol. Chem. 268, 10024-10028.
28. Birchmeier, C. and Gherardi, E. (1998) Developmental roles of HGF/SFand its receptor, the c-met tyrosine kinase. Trends Cell Biol. 8, 404-410.
29. Michalopoulos, G. K. (1995) Hepatocyte growth factor (HGF) and its receptor (Met) in liver regeneration, neoplasia and disease. In: Liver Regeneration and Carcinogenesis: Molecular and Cellular Mechanisms, Jirtle, R. L. (Ed.), pp. 27-49. Academic Press, San Diego.
30. Nakamura, T., Nawa, K. and Ichihara, A. (1984) Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem. Biophys. Res. Commun. 122, 1450-1459.
31. Montesano, R., Matsumoto, K., Nakamura, T. and Orci L. (1991) Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor. Cell 67, 901-908.
32. Andermarcher, E., Surani, M. A. and Gherardi, E. (1996) Coexpression of the HGF/SF and c-met genes during early mouse embryogenesis precedes reciprocal expression in adjacent tissues during organogenesis. Dev. Genet. 18, 254-266.
33. Wojcik, E. J., Sharifpoor, S., Miller, N. A., Wright, T. G., Watering, R., Tremblay, E. A., Swan, K., Mueller, C. R. and Elliott, B. E. (2006) A novel activating function of c-Src and Stat3 on HGF transcription in mammary carcinoma cells. Oncogene 25, 2773-2784.
34. Di Renzo, M. F., Olivero, M., Katsaros, D., Crepaldi, T., Gaglia, P., Zola, P., Sismondi, P. and Comoglio, P. M. (1994) Overexpression of the Met/HGF receptor in ovarian cancer. Int. J. Cancer. 58, 658-662.
35. Di Renzo, M. F., Olivero, M., Giacomini, A., Porte, H., Chastre, E., Mirossay, L., Nordlinger, B., Bretti, S., Bottardi, S., Giordano, S. et al. (1995) Overexpression and amplification of the met/HGF receptor gene during the progression of colorectal cancer. Clin. Cancer Res. 1, 147-154.
36. Di Renzo, M. F., Poulsom, R., Olivero, M., Comoglio, P. M. and Lemoine, N. R. (1995) Expression of the Met/hepatocyte growth factor receptor in human pancreatic cancer. Cancer Res. 55, 1129-1138.
37. Olivero, M., Rizzo, M., Madeddu, R., Casadio, C., Pennacchietti, S., Nicotra, M. R., Prat, M., Maggi, G., Arena, N., Natali, P. G., Comoglio, P. M. and Di Renzo, M. F. (1996) Overexpression and activation of hepatocyte growth factor/scatter factor in human non-small-cell lung carcinomas. Br. J. Cancer 74, 1862-1868.
38. Trovato, M., Vitarelli, E., Grosso, M., Alesci, S., Benvenga, S., Trimarchi, F. and Barresi, G. (2004) Immunoistochemical expression of HGF, c-Met and transcription factor STAT3 in colorectal tumors. Eur. J. Histochem. 48, 291-297.
39. Alla, D.-M. and Berton, Z. (2002) Dysregulation of Met receptor tyrosine kinase activity in invasive tumors. J. Clin. Invest. 109, 863-867.
40. Breuhahn, K., Longerich, T. and Schirmacher, P. (2006) Dysregulation of growth factor signaling in human hepatocellular carcinoma. Oncogene 25, 3787-3800.
41. Guirouilh, J., Le Bail, B., Boussarie, L., Balabaud, C., Bioulac-Sage, P., Desmouliere, A., Schuppan, D. and Rosenbaum, J. (2001) Expression of hepatocyte growth factor in human hepatocellular carcinoma. J. Hepatol. 34, 78-83.
42. Jo, M., Stolz, D. B., Esplen, J. E., Dorko, K., Michalopoulos, G. K. and Strom, S. C. (2000) Cross-talk between growth factor receptor and c-Met signal pathways in transformed cells. J. Biol. Chem. 275, 8806-8811.
43. Wang, R., Ferrell, L. D., Faouzi, S., Maher, J. J. and Bishop, J. M. (2001) Activation of the Met receptor by cell attachment induces and sustains hepatocellular carcinomas in transgenic mice. J. Cell. Biol. 153, 1023-1034.
44. Bhowmick, N. A., Neilson, E. G. and Moses, H. L. (2004) Stromal fibroblasts in cancer initiation and progression. Nature 432, 332-337.
45. Mueller, M. M. and Fusenig, N. E. (2004) Friends or foesbipolar effects of the tumor stroma in cancer. Nat. Rev. 4, 839-849.
46. Sandler, A. B., Johnson, D. H. and Herbst, R. S. (2004) Antivascular andothelial growth factor monoclonals in non-small cell lung cancer. Clin. Cancer Res. 10, 4258 s-4262 s.
47. Bachelder, R. E., Wendt, M. A. and Mercurio, A. M. (2002) Vascular endothelial growth factor promotes breast carcinoma invasion in an autocrine manner by regulating the chemokine receptor CXCR4. Cancer Res. 62, 7203-7206.
48. Orimo, A., Gupta, P. B., Sgroi, D. C., Arenzana-Seisdedos, F., Dalaunay, T., Naeem, R., Carey, V. J., Richardson, A. L. and Weinberg, R. A. (2005) Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121, 335-348.
49. Balkwill, F. (2004) Cancer and the chemokine network. Nat. Rev. Cancer 4, 540-550.
50. Kankuri, E., Cholujova, D., Comajova, M., Vaheri, A. and Bizik, J. (2005) Induction of hepatocyte growth factor/scatter factor by fibroblast clustering directly promotes tumor cell invasiveness. Cancer Res. 65, 9914-9922.
51. Semenza, G. L. (2002) HIF-1 and tumor progression: pathophysiology and therapeutics. Trends Mol. Med. 8, S62-S67.
52. Hockel, M. and Vaupel, P. (2001) Tumor hypoxia: definitions and current clinical, biological, and molecular aspects. J. Natl. Cancer. Inst. 93, 266-276.
53. Ide, T., Kitajima, Y., Miyoshi, A., Ohtsuka, T., Mitsuno, M., Ohtaka, K., Koga, Y. and Miyazaki, K. (2006) Tumor-stromal cell interaction under hypoxia increases the invasiveness of pancreatic cancer cells through the hepatocyte growth factor/c-Met pathway. Int. J. Cancer 119, 2750-2759.
54. Tacchini, L., Dansi, P., Matteucci, E. and Desiderio, M. A. (2001) Hepatocyte growth factor signalling stimulates hypoxia inducile factor-1 (HIF-1) activity in HepG2 hepatoma cells. Carcinogenesis 22, 1363-1371.
55. Pennacchietti, S., Michieli, P., Galluzzo, M., Mazzone, M., Giordano, S. and Comoglio, P. M.(2003) Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. Cancer Cell 3, 347-361, 2003.
56. Weidner, K. M., Sachs, M. and Birchmeier, W. (1993) The Met receptor tyrosine kinase transduces motility, proliferation, and morphogenic signals of scatter factor/hepatocyte growth factor in epithelial cells. J. Cell. Biol. 121, 145-154.
57. Fischer, O. M., Giordano, S., Comoglio, P. M. and Ullrich, A. (2004) Reactive oxygen species mediate Met receptor transactivation by G protein-coupled receptors and the epidermal growth factor receptor in human carcinoma cells. J. Biol. Chem. 279, 28970-28978.
58. FAK) and promotes migration and invasion by oral squamous cell carcinoma cells. J. Biol. Chem. 269, 31807-31813.
59. Pongchairerk, U., Guan, J.-L. and Leardkamolkarn, V. (2005). Focal adhesion kinase and Src phosphorylations in HGF-induced proliferation and invasion of human cholangiocarcinoma cell line, HuCCA-1. World J. Gastroenterol. 11, 5845-5852.
60. Gumbiner, B. M. (2000) Regulation of cadherin adhesive activity. J. Cell Biol. 148, 399-404.
61. Conacci-Sorell, M., Zhurinsky, J. and Ben-Ze'ev, A. (2002) The cadherin-catenin adhesion system in signaling and cancer. J. Clin. Invest. 109, 987-991.
62. Wheelock, M. J. and Johnson, K. R. (2003) Cadherin-mediated cellular signaling. Curr. Opin. Cell Biol. 15, 509-514.
63. Hajra, K. M. and Fearon, E. R. (2002) Cadherin and catenin alterations in human cancer. Genes Chromosomes Cancer 34, 255-268.
64. Fujita, Y., Krause, G., Scheffner, M., Zechner, D., Leddy, H. E. M., Behrens, J., Sommer, T. and Birchmeier, W. (2002). Hakai, a Cbl-like protein, ubiquitinates and induces endocytosis of the E-cadherin complex. Nat. Cell Biol. 4, 222-231.
65. Pece, S. and Gutkind, S. (2002) E-cadherin and Hakai: signaling, remodeling or destruction? Nat. Cell Biol. 4, E72-E74.
66. Grotegut, S., von Schweinitz, D., Christofori, G. and Lehembre, F. (2006) Hepatocyte growth factor induces cell scattering through MAPK/Erg-1-mediated upregulation of Snail. EMBO J. 25, 3534-3545.
67. Matteucci, E., Ridolfi, E. and Desiderio, M. A. (2006) Hepatocyte growth factor differently influences Met-E-cadherin phosphorylation and downstream signaling pathway in twomodels of breast cells. Cell. Mol. Life Sci. 63, 2016-2026.
68. Stuelten, C. H., Da Costa Byfield, S., Arany, P. R., Karpova, T. S., Steler-Stevenson, W. G. and Roberts, A. B. (2005) Breast cancer cells induce stromal fibroblasts to express MMP-9 via secretion of TNF-α and TGF-β. J. Cell Sci. 118, 2143-2153.
69. Blasi, F. and Carmeliet, P. (2002). uPAR: a versatile signaling orchestrator. Nature 3, 932-943.
70. S6K induces expression of matrix metalloproteinase 9 associated with hepatocyte growth factor-mediated invasion in human ovarian cancer cells. Endocrinology 147, 2557-2566
71. Ozaki, I., Mizuta, T., Zhao, G., Zhang, H., Yoshimura, T., Kawazoe, S., Yuichiro, E., Yasutake, T., Hisatomi, A., Takahiro, S. and Yamamoto, K. (2003) Induction of multiple matrix metalloproteinase genes in human hepatocellular carcinoma by hepatocyte growth factor via transcription factor Ets-1. Hepat. Res. 27, 289-301.
72. Jiang, W. G., Davies, G., Martin, T. A., Parr, C., Watkins, G., Mason, M. D. and Mensel, R. E. (2006) Expression of membrane type-1 matrix metalloproteinase, MT1-MMP in human breast cancer and its impact on invasiveness of breast cancer cells. Int. J. Mol. Med. 17, 583-590.
73. Preissner, K. T., Kanse, S. M. and May, A. E. (2000) Urokinase receptor: a molecular organizer in cellular communication. Curr. Opin. Cell Biol. 12, 621-628.
74. Tacchini, L., Matteucci, E., De Ponti, C. and Desiderio, M. A. (2003) Hepatocyte growth factor signaling regulates transactivation of genes belonging to plasminogen activation system via hypoxia inducible factor-1. Exp. Cell Res. 290, 391-401.
75. Ried, S., Jäger, C., Jeffers, M., Vande Woude, G. F., Graeff, H., Schmidt, M. and Lengyel, E. (1999) Activation mechanisms of the urokinase-type plasminogen activator promoter by hepatocyte growth factor/scatter factor. J. Biol. Chem. 274, 16377-16386.
76. Paumelle, R., Talashe, D., Kherrouche, Z., Plaza, S., Leroy, C., Reveneau, S., Vandenbunder, B. and Fafeur, V. (2002) Hepatocyte growth factor/scatter factor activates the ETS1 transcription factor by RAS-RAF-MEK-ERKsignaling pathway. Oncogene 21, 2309-2319.
77. Bajou, K., Lewalle, J.-M., Martinez, C. R., Soria, C., Lu, H., Noël, A. and Foidart, J.-M. (2002) Human breast adenocarcinoma cell lines promote angiogenesis by providing cells with uPA-PAI-1 and by enhancing their expression. Int. J. Cancer 100, 501-506.
78. Nishimura, K., Matsumiya, K., Miura, H., Tsujimura, A., Nonomura, N., Matsumoto, K., Nakamura, T. and Okuyama, A. (2003) Effects of hepatocyte growth factor on urokinase-type plasminogen activator (uPA) and uPA receptor in DU145 prostate cancer cells. Int. J. Androl. 26, 175-179.
79. Lee, K. H., Choi, E. Y., Hyun, M. S., Jang, B. I., Kim, T. N., Kim, S. W., Song, S. K., Kim, J. H. and Kim, J. R. (2006) Hepatocyte growth factor/c-met signaling in regulating urokinase plasminogen activator in human stomach cancer: a potential therapeutic target for human stomach cancer. Korean J. Intern. Med. 21, 20-27.
80. Bauer, T. W., Fan, F., Liu, W., Johnson, M., Parikh, N. U., Parry, G. C., Callahn, J., Mazar, A. P., Gallick, G. E. and Ellis, L. M. (2005) Insulinlike growth factor-I-mediated migration and invasion of human colon carcinoma cells requires activation of c-Met and urokinase plasminogen activator receptor. Ann. Surg. 241, 748-756.
81. Bernards, R. (2003) Cues for migration. Nature 425, 247-248.
82. Rizki, A. and Bissell, M. J. (2004) Homeostasis in the breast: it takes a village. Cancer Cell 6, 1-2.
83. Balkwill, F. (2004) The significance of cancer cell expression of the chemokine receptor CXCR4. Semin. Cancer Biol. 14, 171-179.
84. Darash-Yahna, M., Pikarsky, E., Abramovitch, R., Zeira, E., Pal, B., Karplus, R., Beider, K., Avniel, S., Kasem, S., Galun, E. and Peled, A. (2004) Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis. FASEB J. 18, 1240-1242.
85. Matteucci, E., Locati, M. and Desiderio, M. A. (2005) Hepatocyte growth factor enhances CXCR4 expression favoring breast cancer cell invasiveness. Exp. Cell Res. 310, 176-185.
86. Schioppa, T., Uranchimeg, B., Saccani, A., Biswas, S. K., Doni, A., Rapisarda, A., Bernasconi, S., Saccani, S., Nebulosi, M., Vago, L., Mantovani, A., Melillo, G. and Sica, A. (2003) Regulation of the chemokine receptor CXCR4 by hypoxia. J. Exp. Med. 198, 1391-1402.
87. Bachelder, R. E., Wendt, M. A. and Mercurio, A. M. (2002) Vascular endothelial growth factor promotes breast carcinoma invasion in an autocrine manner by regulating the chemokine receptor CXCR4. Cancer Res. 62, 7203-7206.
88. Eccles, S. A. and Paon, L. (2005). Breast cancer metastasis: when, where, how? Lancet 365, 1006-1007.
89. Demidenko, Z. N., Rapisarda, A. M., Garayoa, M., Giannakakou, P., Melillo, G. and Blagosklonny, M. V. (2005) Accumulation of hypoxia-inducible factor-1α is limited by transcription-dependent depletion. Oncogene 24, 4829-4838.
90. Pouysségur, J., Dayan, F. and Mazure, N. M. (2006) Hypoxia signaling in cancer and approaches to enforce tumor regression. Nature 44, 437-443.
91. Lederle, W., Stark, H.-J., Skobe, M., Fusenig, N. E. and Mueller, M. M. (2006) Platelet-derived growth factor-BB controls epithelial tumor phenotype by differential growth factor regulation in stromal cells. Am. J. Pathol. 169, 1767-1783.
92. Semenza, G. L. (2000) HIF-1 and human disease: one highly involved factor. Genes Dev. 14, 1983-1991.
93. Le, Q.-T., Denko, N. C. and Giaccia, A. J. (2004) Hypoxic gene expression and metastasis. Cancer Metastasis Rev. 23, 293-310.
94. Tacchini, L., DePonti, C., Matteucci, E., Follis, R. and Desiderio, M. A. (2004) Hepatocyte growth factor-activated NF-κB regulates HIF-1 activity and ODC expression, implicated in survival, differently in different carcinoma cell lines. Carcinogenesis 25, 2089-2100.
95. Kabe, Y., Ando, K., Hirao, S., Yoshida, M. and Handa, H. (2005) Redox regulation of NF-κB activation: distinct redox regulation between the cytoplasm and the nucleus. Antioxidants Redox Signal. 7, 395-403.
96. Karin, M. (2006) Nuclear factor-κB in cancer development and progression. Nature 441, 431-436.
97. Perkins, N. D. (2004) Regulation of NF-κB by atypical activators and tumor suppressors. Biochem. Soc. Transact. 32, 936-939.
98. Haddad, J. J. and Harb, H. L. (2005) Cytokines and the regulation of hypoxia-inducible factor (HIF-)1α. Int. Immunopharmacol. 5, 461-483.
99. Hellwig-Burgel, T., Rutkowski, K., Metzen, E., Fandrey, J. and Jelkmann, W. (1999) Interleukin-1 and tumor necrosis factor-α stimulate DNA binding of hypoxia-inducible factor-1. Blood 94, 1561-1567.
100. Matsuda, Y. and Nakamura, T. (1993) Molecular biology of hepatocyte gowth factor (HGF) Nippon. Rinsho 51, 435-445.
101. Fukuda, R., Hirota, K., Fan, F., Do Jung, Y., Ellis, L. M. and Semenza, G. L. (2002) Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells. J. Biol. Chem. 277, 38205-38211.
102. Jiang, B.-H., Jiang, G., Zheng, J. Z., Lu, Z., Hunter, T. and Vogt, P. K. (2001) Phosphatidylinositol 3-kinase signaling controls levels of hypoxia-inducible factor 1. Cell Growth Differ. 12, 363-369.
103. Bilton, R. L. and Booker, G. W. (2003) The subtle side to hypoxia inducible factor (HIFα) regulation. Eur. J. Biochem. 270, 791-798.
104. Bárdos, J. I. and Ashcroft, M. (2005) Negative and positive regulation of HIF-1: a complex network. Biochim. Biophys. Acta 1755, 107-120.
105. Mottet, D., Dumont, V., Deccache, Y., Demazy, C., Ninane, N., Raes, M. and Michiels, C. (2003) Regulation of hypoxia-inducible factor-1α protein level during hypoxic conditions by the phosphatidylinositol 3-kinase/Akt/ Glycogen synthase kinase 3β pathway in HepG2 cells. J. Biol. Chem. 278, 31277-31285.
106. Bergers, G. and Benjamin, L. E. (2003) Tumorigenesis and the angiogenic switch. Nat. Rev. Cancer 3, 401-410.
107. Carmeliet, P. and Jain, R. K. (2000) Angiogenesis in cancer and other diseases. Nature 407, 249-257.
108. Hanahan, D. and Folkman, J. (1996) Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86, 353-364.
109. Abounader, R. and Laterra, J. (2005) Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesis. Neuro-Oncology 7, 436-451.
110. Lyden, D., Hattori, K., Dias, S., Costa, C., Blaikie, P., Butros, L., Chadburn, A., Heissig, B., Marks, W., Witte, L., Wu, Y., Hicklin, D., Zhu, Z., Hackett, N. R., Crystal, R. G., Moore, M. A., Hajjar, K. A., Manova, K., Benezra, R. and Rafii, S. (2001) Impaired recruitment of bone-marrow-derived endothelial and hemopoietic precursor cells blocks tumor angiogenesis and growth. Nat. Med. 7, 1194-1201.
111. Ikeda, E., Achen, M. G., Breier, G. and Risau, W. (1995) Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells. J. Biol. Chem. 270, 19763-19766.
112. Mandriota, S. J. and Pepper, M. S. (1998) Regulation of angiopoietin-2 mRNA levels in bovine microvascular endothelial cells by cytokines and hypoxia. Circ. Res. 83, 852-859.
113. Lamszus, K., Jin, L., Fuchs, A., Shi, E., Chowdhury, S., Yao, Y., Poleverini, P. J., Laterra, J., Goldberg, I. D. and Rosen, E. M. (1997) Scatter factor stimulates tumor growth and tumor angiogenesis in human breast cancers in the mammary fat pads of nude mice. Lab. Invest. 76, 339-353.
114. Kuba, K., Matsumoto, K., Date, K., Shimura, H., Tanaka, M. and Nakamura, T. (2000) HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice. Cancer Res. 60, 6737-6743.
115. Gerrisen, M. E. (2005) HGF and VEGF: a dynamic duo. Circ. Res. 96, 272-273.
116. Zhang, Y.-W., Su, Y., Volpert, O. V. and Vande Woude, G. F. (2003) Hepatocyte growth factor/scatter factor mediates angiogenesis through positive VEGF and negative thrombospondin 1 regulation. Proc. Natl. Acad. Sci. USA 100, 12718-12723.
117. Fan, S., Wang, J.-A., Yuan, R.-Q., Rockwell, S., Andres, J., Zlatapolskiy, A., Goldberg, I. D. and Rose, E. M. (1998) Scatter factor protects epithelial and carcinoma cells against apoptosis induced by DNA-damaging agents. Oncogene 17, 131-141.
118. Bowers, D. C., Fan, S., Walter, K. A., Abounader, R., Williams, J. A., Rosen, E. M. and Laterra, J. (2000) Scatter factor/hepatocyte growth factor protects against cytotoxic death in human glioblastoma via phosphatidylinositol 3-kinase- and AKT-dependent pathways. Cancer Res. 60, 4277-4283.
119. Conner, E. A., Wirth, P. J., Kiss, A., Santoni-Rugiu, E. and Thorgeirsson, S. S. (1997) Growth inhibition and induction of apoptosis by HGF in transformed liver epithelial cells. Biochem. Biophys. Res. Commun. 236, 396-401.
120. Matteucci, E., Castoldi, R. and Desiderio, M. A. (2001) Hepatocyte growth factor induces pro-apoptotic genes in HepG2 hepatoma but not in B16-F1 melanoma cells. J. Cell. Physiol. 186, 387-396.
121. Matteucci, E., Modora, S., Simone, M. and Desiderio, M. A. (2001) Hepatocyte growth factor induces apoptosis through the extrinsic pathway in hepatoma cells: favoring role of hypoxia-inducible factor-1 deficiency. Oncogene 22, 4062-4073.
122. Coltella, N., Rasola, A., Nano, E., Bardella, C., Fassetta, M., Filigheddu, N., Graziani, A., Comoglio, P. M. and Di Renzo, M. F. (2006) p38 MAPK turns hepatocyte growth factor to a death signal that commits ovarian cancer cells to chemotherapy-induced apoptosis. Int. J. Cancer 118, 2981-2990.
123. Fry, C. J. and Farnham, P. J. (1999). Context-dependent transcriptional regulation. J. Biol. Chem. 274, 29583-29586.
124. Martin, G. S. (2003) Cell signaling and cancer. Cancer Cell 4, 167-174.
125. Maroni, P., Bendinelli, P., Matteucci, E. and Desiderio, M. A. (2007) HGF induces CXCR4 and CXCL-12 mediated tumor invasion through Ets1 and NF-κB. Carcinogenesis 28, 267-279.
126. Oikawa, T. (2004) ETS transcription factors: possible targets for cancer therapy. Cancer Sci. 95, 626-633
127. Dittmer, J. (2003) The biology of Ets1 proto-oncogene. Mol. Cancer 2, 1-21.
128. Shim, H., Lau, S. K., Devi, S., Yoon, Y., Cho, H. T. and Liang, Z. (2006) Lower expression of CXCR4 in lymph node metastases than in primary breast cancers: potential regulation by ligand-dependent degradation and HIF-1α. Biochem. Biophys. Res. Commun. 346, 252-258.
129. Behrens, J., von Kries, J. P., Kuhl, M., Bruhn, L., Wedlich, D., Grosschedl, R. and Birchmeier, W. (1996) Functional interaction of beta-catenin with the transcription factor LEF-1. Nature 382, 638-642.
130. Yap, A. S. and Kovacs, E. M. (2003) Direct catenin-activated cell signaling: a view from the plasma membrane. J. Cell Biol. 160, 11-16.
131. Papkoff, J. and Aikawa, M. (1998) WNT-1 and HGF regulate GSK3β activity and β-catenin signaling in mammary epithelial cells. Biochem. Biophys. Res. Commun. 247, 851-858.
132. Gottardi, C. J., Wong, E. and Gumbiner B. M. (2001) E-cadherin suppresses cellular transformation by inhibiting β-catenin signalling in an adhesion-independent manner. J. Biol. Chem. 153, 1049-1060.
133. Danilkovitch-Miagkova, A., Miagkov, A., Skeel, A., Nakaigawa, N., Zbar, B. and Leonard, E. J. (2001) Oncogenic mutants of Ron and Met receptor tyrosine kinase cause activation of the β-catenin pathway. Mol. Cell. Biol. 21, 5857-5868.
134. Monga, S. P.S., Mars, W. M., Pediaditakis, P., Bell, A., Mulé, K., Bowen, W. C., Wang, X., Zarnegar, R. and Michalopoulos, G. K. (2002) Hepatocyte growth factor induces Wnt-independent nuclear translocation of β-catenin after Met-β-catenin dissociation in hepatocytes. Cancer Res. 62, 2064-2071.
135. Herynk, M. H., Tsan, R., Radinsky, R. and Gallick, G. E. (2003) Activation of c-Met in colorectal carcinoma cells leads to constitutive association of tyrosine-phosphorylayed β-catenin. Clin. Exp. Metastasis 20, 291-300.
136. Boon, E. M.J., van der Neut, R., van de Wetering, M., Clevers, H. and Pals, S. T. (2002) Wnt signaling regulates expression of the receptor tyrosine kinase Met in colorectal cancer. Cancer Res. 62, 5126-5128.
137. Apte, U., Zeng, G., Muller, P., Tan, X., Micsenyi, A., Cieply, B., Dai, C., Liu, Y., Kaestner, K. H. and Monga, S. P.S. (2006) Activation of Wnt/β-catenin pathway during hepatocyte growth factor-induced hepatomegaly in mice. Hepatology 44, 992-1002.
138. Rehman, A. O. and Wang, C.-Y. (2006) Notch signaling in the regulation of tumor angiogenesis. Trends Cell Biol. 16, 293-300.
139. Stella, M. C., Trusolino, L., Pennacchietti, S. and Comoglio, P. M. (2005) Negative feedback regulation of Met-dependent invasive growth by Notch. Mol. Cell. Biol. 25, 3982-3996.
140. Bergstrom, J. D., Westermark, B. and Heldin, N. E. (2000) Epidermal growth factor receptor signaling activates met in human anaplastic thyroid carcinoma. Exp. Cell Res. 259, 293-299.
141. Polo, S. and Di Fiore, P. P. (2006) Endocytosis conducts the cell signaling orchestra. Cell 124, 897-900.
142. Kermorgant, S., Zicha, D. and Parker, P. J. (2004) PKC controls HGF-dependent c-Met traffic, signaling and cell migration. EMBO J. 23, 3721-3734.